Literature DB >> 2299529

Detection of antigens of larval Taenia solium in the cerebrospinal fluid of patients with the use of HPLC and ELISA.

L Choromanski1, J J Estrada, R E Kuhn.   

Abstract

The cerebrospinal fluid (CSF) obtained from patients suspected of having neurocysticerosis (79 samples), as well as from control patients (without neurological symptoms), was separated using a high performance liquid chromatography gel filtration column. During the chromatographic separation, the eluted fractions were collected separately according to distinctive peaks. The elution characteristics of CSF components were identified by aligning more than 100 chromatograms and 6 distinctive peaks, eluting in consistent positions. Samples of each peak were tested in an enzyme-linked immunosorbent assay (ELISA) for the presence of larval antigens. Forty-four of the suspected 79 cases were found to have larval antigens in their CSF and these antigens were detected in peak no. 2, the mean of which is approximately 110,000 molecular weight. Also, in some cases, larval antigens were found in peak no. 1; however, we were able to detect them in only 23 CSF samples out of 44 CSF samples in which larval antigens were present in peak no. 2. Nine of these 23 CSF samples (derived from 79 patients in which neurocysticercosis was suspected) were later confirmed by histopathology. Values of ELISA readings of 5 CSF samples obtained from control patients (0.054 +/- 0.064) were considered negative. Thus, in 44 of 79 CSF samples from patients suspected of having neurocysticercosis, the ELISA values were highly positive (0.551 +/- 0.293). The remaining 35 CSF samples gave ELISA readings of 0.092 +/- 0.062, which were not significantly different from values obtained with CSF of control patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2299529

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  3 in total

1.  Cysticercus antigens in cerebrospinal fluid samples from patients with neurocysticercosis.

Authors:  A X Pardini; A J Vaz; L Dos Ramos Machado; J A Livramento
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru.

Authors:  H H Garcia; L J Harrison; R M Parkhouse; T Montenegro; S M Martinez; V C Tsang; R H Gilman
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Jul-Aug       Impact factor: 2.184

Review 3.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.